Real-Life Efficacy of Bevacizumab Treatment for Macular Edema Secondary to Central Retinal Vein Occlusion according to Pro Re Nata or Treat-and-Extend Regimen in Eyes with or without Epiretinal Membrane

PURPOSE: To present real-life data of patients with macular edema (ME) secondary to central retinal vein occlusion (CRVO) treated with bevacizumab (BVZ); determine the possible influence of epiretinal membrane (ERM) on treatment efficacy; and compare treatment outcomes in a treat-and-extend regimen...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamam, Moustafa, Lagali, Neil, Abdulnour, Elie, Setterud, Helen, Johansson, Björn, Mirabelli, Pierfrancesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550471/
https://www.ncbi.nlm.nih.gov/pubmed/36225608
http://dx.doi.org/10.1155/2022/6288582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550471/
https://www.ncbi.nlm.nih.gov/pubmed/36225608
http://dx.doi.org/10.1155/2022/6288582

Ejemplares similares